Skip to main content

Month: May 2021

Golar LNG Limited – Q1 2021 results presentation

Golar LNG’s 1st Quarter 2021 results will be released before the NASDAQ opens on Thursday, May 20, 2021. In connection with this a webcast presentation will be held at 3:00 P.M (London Time) on Thursday, May 20, 2021. The presentation will be available to download from the Investor Relations section at www.golarlng.com We recommended that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call dial-in information below.  Please dial in 10-15 minutes prior to the start time to allow time for call handling. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions...

Continue reading

Bonanza Creek and Extraction to Combine in Merger of Equals, Creating Civitas Resources – a New Colorado Energy Leader and the State’s First Net-Zero Oil & Gas Producer

DENVER, May 10, 2021 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (“Bonanza Creek”) and Extraction Oil & Gas, Inc. (NASDAQ: XOG) (“Extraction”), today announced that they have entered into a definitive agreement to combine in an all-stock merger of equals. The combined company, to be named Civitas Resources, Inc. (“Civitas”), will be the largest pure-play energy producer in Colorado’s Denver-Julesburg (DJ) Basin, with an aggregate enterprise value of approximately $2.6 billion (based on the closing share prices of Bonanza Creek and Extraction on May 7, 2021). TRANSACTION HIGHLIGHTSThe merger will create a leading energy producer in Colorado’s DJ Basin, a basin characterized by low operating costs, extensive infrastructure, ample takeaway, multiple producing horizons and responsible energy production. The combined...

Continue reading

BPSmart To Integrate Ipsidy’s Trusted Biometric Identity Verification Services Into Its Digital Assistant ChatBot Platform

LONG BEACH, NY and LIMA PERU, May 10, 2021 (GLOBE NEWSWIRE) — Ipsidy Inc. (www.ipsidy.com) [OTCQB: IDTY], a leading provider of an Identity as a Service (IDaaS) platform delivering a suite of secure, mobile, biometric identity verification and authentication solutions, and BPSmart, an innovative technology provider servicing the North American and Latin American markets, announced that BPSmart will deploy Ipsidy’s biometric identity verification services to verify each customer’s identity when interacting with their AI-Powered Chat-based Digital Assistant Platform. Intelligent chatbot applications perform online sales, customer and technical support conversations via text or text-to-speech, in lieu of providing direct contact with a live human. Increased consumer demand for seamless self-service as well as the benefits of reduced...

Continue reading

BIO-key MobileAuth Aims to Obsolete Traditional Authentication Methods

A different authentication approach offering the highest levels of integrity, availability, security, and accuracy WALL, N.J., May 10, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions featuring biometrics, today introduced its new mobile app, BIO-key MobileAuth™ with PalmPositive™ the latest among over sixteen strong authentication factors available for BIO-key’s PortalGuard® Identity-as-a-Service (IDaaS) platform. MobileAuth’s fast, touchless biometric user authentication – using a palm scan – works with any Android or iOS device to provide the unprecedented combination of a simple, privacy-protected, and convenient user experience with the identity integrity and availability that enterprises require. While multi-factor authentication...

Continue reading

Aleafia Health Completes Clinic Assets Transaction with Myconic Capital Corp.

TORONTO, May 10, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its wholly-owned subsidiaries, Canabo Medical Corporation (“Canabo”) and GrowWise Health Limited (“GrowWise”), (together the “Vendors”) have closed a transaction (the “Transaction”) with Myconic Capital Corp. (CSE: MEDI) (“Myconic”) whereby the Vendors sold certain of their respective clinic assets to Myconic. Additionally, Canabo has agreed to continue to staff and generally operate the clinics for the benefit of Myconic for a period of ten years, through a Clinic Services and License Agreement (the “Services Agreement”) between Canabo and Myconic, ensuring that there will be no interruption to medical services offered to existing patients. Pursuant to an Asset Purchase Agreement,...

Continue reading

ARKO to Report First Quarter 2021 Financial Results on May 13, 2021

RICHMOND, Va., May 10, 2021 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (the “Company”) today announced that the Company will report results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021 before the markets open in the United States. The Company will host a conference call to discuss these results at 10:00 a.m. Eastern Time on May 13, 2021. Investors interested in participating in the live call can dial 877-605-1792 or 201-689-8728. A telephone replay will be available approximately two hours after the call concludes through May 27, 2021, by dialing 877-660-6853 or 201-612-7415 and entering confirmation code 13718973. There will also be a simultaneous, live webcast available on the Investor Relations section of the Company’s website at https://www.arkocorp.com/. The webcast will archived for 30 days. About...

Continue reading

The Software Report Names FTI Consulting’s Jordan Rae Kelly to Top 25 Women Leaders in Cybersecurity List

WASHINGTON, May 10, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Jordan Rae Kelly, a Senior Managing Director and Head of Cybersecurity for the Americas, has been named to The Software Report’s Top 25 Women Leaders in Cybersecurity 2021 list. At FTI Consulting, Ms. Kelly advises clients on a broad range of cybersecurity matters involving incident response, insider threats, intellectual property, vendor management, compliance, regulation, risk management and forensic investigations. “This is another very well-deserved recognition for Jordan,” said Anthony J. Ferrante, Global Head of Cybersecurity at FTI Consulting. “She proves herself an expert day-in and day-out as she advises clients with diligence and innovation through their most complex cybersecurity challenges. It’s no surprise to me that The...

Continue reading

Mydecine to Participate in the Benzinga Global Small Cap Conference on May 13th

DENVER, May 10, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, today announced that Josh Bartch, CEO of Mydecine, will participate in the Benzinga Global Small Cap Conference to be hosted virtually on Thursday, May 13, 2021. Mr. Bartch will speak on the panel titled Investing in the Mental Health Crisis Through Psychedelics at 4:15 p.m. ET. To attend, register here. For more information about the conference, or to schedule a one-on-one meeting with Mydecine management, please contact KCSA Strategic Communications at MYCO@kcsa.com. About Mydecine Innovations GroupMydecine Innovations Group™ (NEO:MYCO)...

Continue reading

Heat Biologics Appoints Anthony Manning, Ph.D. as Chief Scientific Advisor

DURHAM, N.C., May 10, 2021 (GLOBE NEWSWIRE) —  Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced the appointment of Anthony Manning, Ph.D. as Chief Scientific Advisor. Dr. Manning will be responsible for strategic initiatives to accelerate the development of Heat Biologics’ product portfolio. Dr. Manning brings over three decades of experience in immunology and autoimmune disease research and development. Most recently, Dr. Manning served as Chief Scientific Officer and Head of Research at Momenta Pharmaceuticals, a biotechnology company focused on biologic therapeutics to treat rare immune-mediated diseases. At Momenta, Dr. Manning...

Continue reading

QuoteMedia Q1 2021 Financial Results and Investors’ Conference Call May 13, 2021

PHOENIX, May 10, 2021 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, today announced that its earnings for its quarter ended March 31, 2021 will be released the morning of May 13, 2021. That same day, the company will host a conference call at 2:00 PM Eastern time to discuss the financial results and provide a business update. Conference Call Details: Date: May 13, 2021 Time: 2:00 PM Eastern Dial-in numbers: 877-876-9173, 785-424-1667 Conference ID: QUOTEMEDIA An audio rebroadcast of the call will be available later at: www.quotemedia.com About QuoteMedia QuoteMedia is a leading software developer and cloud-based syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages, and financial services companies....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.